189 related articles for article (PubMed ID: 19539066)
1. Humoral response to cancer as a tool for biomarker discovery.
Desmetz C; Cortijo C; Mangé A; Solassol J
J Proteomics; 2009 Aug; 72(6):982-8. PubMed ID: 19539066
[TBL] [Abstract][Full Text] [Related]
2. Identifying autoantibody signatures in cancer: a promising challenge.
Desmetz C; Maudelonde T; Mangé A; Solassol J
Expert Rev Proteomics; 2009 Aug; 6(4):377-86. PubMed ID: 19681673
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of proteomic strategies to identify antibodies resulting from the humoral immune response to cancer].
Desmetz C; Mangé A; Solassol J
Med Sci (Paris); 2008 Dec; 24(12):1071-6. PubMed ID: 19116117
[TBL] [Abstract][Full Text] [Related]
4. Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer.
Lu H; Goodell V; Disis ML
J Proteome Res; 2008 Apr; 7(4):1388-94. PubMed ID: 18311901
[TBL] [Abstract][Full Text] [Related]
5. Serum autoantibodies as biomarkers for early cancer detection.
Tan HT; Low J; Lim SG; Chung MC
FEBS J; 2009 Dec; 276(23):6880-904. PubMed ID: 19860826
[TBL] [Abstract][Full Text] [Related]
6. High throughput proteomic strategies for identifying tumour-associated antigens.
Gunawardana CG; Diamandis EP
Cancer Lett; 2007 Apr; 249(1):110-9. PubMed ID: 17306453
[TBL] [Abstract][Full Text] [Related]
7. Identification of tumor antigens by using proteomics.
Le Naour F
Methods Mol Biol; 2007; 360():327-34. PubMed ID: 17172737
[TBL] [Abstract][Full Text] [Related]
8. Protein arrays as tools for serum autoantibody marker discovery in cancer.
Kijanka G; Murphy D
J Proteomics; 2009 Aug; 72(6):936-44. PubMed ID: 19258055
[TBL] [Abstract][Full Text] [Related]
9. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA).
Hamrita B; Chahed K; Kabbage M; Guillier CL; Trimeche M; Chaïeb A; Chouchane L
Clin Chim Acta; 2008 Jul; 393(2):95-102. PubMed ID: 18424265
[TBL] [Abstract][Full Text] [Related]
10. A new method combining sequential immunoaffinity depletion and differential in gel electrophoresis to identify autoantibodies as cancer biomarkers.
Grandjean M; Dieu M; Raes M; Feron O
J Immunol Methods; 2013 Oct; 396(1-2):23-32. PubMed ID: 23916966
[TBL] [Abstract][Full Text] [Related]
11. Immunoproteomics to identify tumor-associated antigens eliciting humoral response.
Mou Z; He Y; Wu Y
Cancer Lett; 2009 Jun; 278(2):123-129. PubMed ID: 18930343
[TBL] [Abstract][Full Text] [Related]
12. [Serum autoantibodies profiling and early-stage cancer detection].
Desmetz C; Lacombe J; Mange A; Maudelonde T; Solassol J
Med Sci (Paris); 2011; 27(6-7):633-8. PubMed ID: 21718648
[TBL] [Abstract][Full Text] [Related]
13. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients.
Zhou SF; Xie XX; Bin YH; Lan L; Chen F; Luo GR
Clin Chim Acta; 2006 Apr; 366(1-2):274-80. PubMed ID: 16356486
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the humoral immune response to cancer.
Murphy MA; O'Leary JJ; Cahill DJ
J Proteomics; 2012 Aug; 75(15):4573-9. PubMed ID: 22300580
[TBL] [Abstract][Full Text] [Related]
15. Mapping the high throughput SEREX technology screening for novel tumor antigens.
Zhou S; Yi T; Zhang B; Huang F; Huang H; Tang J; Zhao X
Comb Chem High Throughput Screen; 2012 Mar; 15(3):202-15. PubMed ID: 22221053
[TBL] [Abstract][Full Text] [Related]
16. Strategies for plasma proteomic profiling of cancers.
Omenn GS
Proteomics; 2006 Oct; 6(20):5662-73. PubMed ID: 16991194
[TBL] [Abstract][Full Text] [Related]
17. [The therapeutic contribution of proteomic approaches in cancers].
Hamrita B; Nasr HB; Kabbage M; Hamann P; Kuhn L; Guillier C; Remadi S; Chaieb A; Khairi H; Chouchane L; Chahed K
Gynecol Obstet Fertil; 2011 Feb; 39(2):87-93. PubMed ID: 21317010
[TBL] [Abstract][Full Text] [Related]
18. Evolution of the strategies for screening and identifying human tumor antigens.
Wang Y; Yang J; Li Z; Yang S
Curr Protein Pept Sci; 2014; 15(8):819-27. PubMed ID: 25345657
[TBL] [Abstract][Full Text] [Related]
19. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM
Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361
[TBL] [Abstract][Full Text] [Related]
20. Novel technologies for cancer biomarker discovery: humoral proteomics.
Shoshan SH; Admon A
Cancer Biomark; 2007; 3(3):141-52. PubMed ID: 17611305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
